{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T03:40:12Z","timestamp":1719114012645},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.remn.2017.01.014","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T23:18:16Z","timestamp":1489879096000},"page":"241-246","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of 18 F-Choline PET\/CT in guiding biopsy in patients with risen PSA levels and previous negative biopsy for prostate cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"G.A.","family":"Jim\u00e9nez Londo\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Garc\u00eda Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Amo-Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"F\u00fanez Mayorga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"L\u00f3pez Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Talavera Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gutierrez Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gonz\u00e1lez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"de la Torre P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.M.","family":"Soriano Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2017.01.014_bib0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bju.12854","article-title":"Guideline of guidelines: prostate cancer screening","volume":"114","author":"Loeb","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.remn.2017.01.014_bib0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1148\/radiol.13122233","article-title":"Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales","volume":"269","author":"Rosenkrantz","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.remn.2017.01.014_bib0175","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1148\/radiol.14131584","article-title":"Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy","volume":"272","author":"Vach\u00e9","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.remn.2017.01.014_bib0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.ju.0000142099.80156.85","article-title":"Prostate cancer localization with 18fluorine fluorocholine positron emission tomography","volume":"173","author":"Kwee","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.remn.2017.01.014_bib0185","first-page":"1249","article-title":"Imaging prostate cancer with 11C-choline PET\/CT","volume":"47","author":"Reske","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2017.01.014_bib0190","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00259-004-1755-y","article-title":"Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy","volume":"32","author":"Yamaguchi","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.01.014_bib0195","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.juro.2006.04.015","article-title":"11C-choline positron emission tomography\/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy","volume":"176","author":"Martorana","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.remn.2017.01.014_bib0200","first-page":"1642","article-title":"Detection and localization of prostate cancer: correlation of (11) C-choline PET\/CT with histopathologic step-section analysis","volume":"46","author":"Farsad","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2017.01.014_bib0205","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00259-008-0716-2","article-title":"[(11)C]choline uptake with PET\/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumor stage and anti-androgenic therapy","volume":"35","author":"Giovacchini","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.01.014_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00259-006-0190-7","article-title":"Value of 11C-choline PET and PET\/CT in patients with suspected prostate cancer","volume":"34","author":"Scher","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.01.014_bib0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cpet.2015.05.004","article-title":"PET\/computed tomography in the individualization of treatment of prostate cancer","volume":"10","author":"Ceci","year":"2015","journal-title":"PET Clin"},{"key":"10.1016\/j.remn.2017.01.014_bib0220","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.remn.2017.01.014_bib0225","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ejca.2013.09.002","article-title":"Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory","volume":"51","author":"Arnold","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.remn.2017.01.014_bib0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.remn.2017.01.014_bib0235","unstructured":"American Cancer Society. American Cancer Society recommendations for prostate cancer early detection. http:\/\/www.cancer.org\/acs\/groups\/cid\/documents\/webcontent\/003182-pdf.pdf [last medical review 4 Jan 2016]."},{"key":"10.1016\/j.remn.2017.01.014_bib0240","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrclinonc.2009.18","article-title":"Is it time to consider a role for MRI before prostate biopsy","volume":"6","author":"Ahmed","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.remn.2017.01.014_bib0245","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent-update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.remn.2017.01.014_bib0250","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/rg.313105139","article-title":"Advancements in MR imaging of the prostate: from diagnosis to interventions","volume":"31","author":"Bonekamp","year":"2011","journal-title":"Radiographics"},{"key":"10.1016\/j.remn.2017.01.014_bib0255","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2214\/AJR.12.10178","article-title":"The expanding role of MRI in prostate cancer","volume":"201","author":"Murphy","year":"2013","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.remn.2017.01.014_bib0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urolonc.2015.01.004","article-title":"Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results","volume":"33","author":"Abdi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.remn.2017.01.014_bib0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.urolonc.2014.09.004","article-title":"Magnetic resonance imaging-targeted vs. conventional transrectal ultrasound-guided prostate biopsy: single-institution, matched cohort comparison","volume":"33","author":"Kim","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.remn.2017.01.014_bib0270","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/iju.12258","article-title":"Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4\u201310ng\/mL and normal digital rectal examination","volume":"21","author":"Javali","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.remn.2017.01.014_bib0275","first-page":"18","article-title":"Pitfalls in interpreting mp-MRI of the prostate: a pictorial review with pathologic correlation","author":"Panebianco","year":"2015","journal-title":"Insights Imaging"},{"key":"10.1016\/j.remn.2017.01.014_bib0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00259-015-3202-7","article-title":"PET\/CT with (11) C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data","volume":"43","author":"Fanti","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.01.014_bib0285","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00259-007-0686-9","article-title":"The value of 18F-choline PET\/CT in patients with elevated PSA-level and negative prostate needle biopsy for localization of prostate cancer","volume":"35","author":"Igerc","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.01.014_bib0290","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000083551","article-title":"11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging","volume":"74","author":"Yoshida","year":"2005","journal-title":"Urol Int"},{"key":"10.1016\/j.remn.2017.01.014_bib0295","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00259-002-0881-7","article-title":"Visualization of bladder cancer using (11)C-choline PET: first clinical experience","volume":"29","author":"de Jong","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.01.014_bib0300","first-page":"238","article-title":"Salvage radiotherapy in prostate cancer patients. Planning, treatment response and prognosis using (11)C-choline PET\/CT","volume":"35","author":"Garc\u00eda","year":"2016","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remn.2017.01.014_bib0305","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.eururo.2008.04.030","article-title":"11C-choline positron emission tomography\/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms","volume":"54","author":"Schiavina","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.remn.2017.01.014_bib0310","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1148\/radiol.09090413","article-title":"18F choline PET-CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients","volume":"254","author":"Beheshti","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.remn.2017.01.014_bib0315","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1464-410X.2012.11150.x","article-title":"[18F]fluoromethylcholine (FCH) positron emission tomography\/computed tomography (PET\u2013CT) for lymph node staging of prostate cancer: a prospective study of 210 patients","volume":"110","author":"Poulsen","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.remn.2017.01.014_bib0320","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s00259-016-3350-4","article-title":"Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons","volume":"43","author":"Evangelista","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16301895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16301895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T03:26:28Z","timestamp":1719113188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X16301895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2253654X16301895"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2017.01.014","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of 18F-Choline PET\/CT in guiding biopsy in patients with risen PSA levels and previous negative biopsy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2017.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}